Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qasim Khalil

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Southern Medical Journal|March 13, 2010
Screening Veterans Affairs patients with iron deficiency for celiac diseaseRizwan Kibria, Salma Akram, Syed A Ali, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 28, 2007
Thrombophilia-hypofibrinolysis and atherothrombotic cardiovascular disease < or = age 45 yearsCharles J Glueck, Jitender Munjal, Dawit Aregawi, et al.
Clinical Therapeutics|July 25, 2006
Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapiesCharles J Glueck, Dawit Aregawi, Mahlia Agloria, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Southern Medical Journal|March 13, 2010
Screening Veterans Affairs patients with iron deficiency for celiac diseaseRizwan Kibria, Salma Akram, Syed A Ali, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 28, 2007
Thrombophilia-hypofibrinolysis and atherothrombotic cardiovascular disease < or = age 45 yearsCharles J Glueck, Jitender Munjal, Dawit Aregawi, et al.
Clinical Therapeutics|July 25, 2006
Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapiesCharles J Glueck, Dawit Aregawi, Mahlia Agloria, et al.
Pageof 2